Movesense Oy of Vantaa at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers OEM

Movesense Oy

Tammiston Kauppatie 7A, 01510 Vantaa
Finland
Telephone +358 9 875870

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Wearable Technologies AG

Hall map

MEDICA 2021 hall map (Hall 12): stand D21

Fairground map

MEDICA 2021 fairground map: Hall 12

Contact

Terho Lahtinen

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Visit us

Hall 12 / D21

15 Nov 2021

Topic

08:00

Accelerating the development of medical wearables with an open sensor platform

Visitors to the stand can hear from two healthtech innovators Heart2Save and Ainone about their experiences of using Movesense sensor technology to bring new wearable medical solutions to market, and learn how to use the open, programmable Movesense movement and ECG sensor for commercializing their own wearable sensor ideas.

A representative from cardiology start-up Heart2Save, will present its Awario analysis service, a solution that uses the ECG feature of the Movesense sensor with AI based algorithms, allowing users to identify heart arrythmias anytime, anywhere. Awario analyses the ECG to determine whether there is a potentially dangerous atrial fibrillation or harmless extrasystoles. Linked to a smartphone, it generates a normal ECG strip to enable a clinician to analyse the results quickly by selecting only the relevant reports.

Finnish start-up Ainone will talk about how it harnessed tested and certified Movesense technology to launch Ainone Balance, a balance measurement solution for assessing neurological performance. Ainone uses data captured via the Movesense sensor to analyze upper body movement while patients perform different balance tests, such as standing on one foot – eyes open and closed – or on hard or soft ground and compares the results to a unique reference database to monitor changes in human performance. Its applications include elite sports, elderly care, daily balance assessment, and monitoring patient recovery from lower limb injuries and concussions.

Both solutions benefited from Movesense’s open, programmable, off-the-shelf sensor technology to help them overcome the challenges of building and testing hardware and bring healthcare solutions to the market quicker. The Movesense device is a wearable movement and ECG sensor that is classified as a Class IIa medical device accessory under the EU Medical Device Directive. It is small and lightweight (9,4g / 0.33oz with battery),features wireless data transmission with Bluetooth Low Energy, and is available with custom branding and firmware.

More Less

16 Nov 2021

Topic

08:00

Accelerating the development of medical wearables with an open sensor platform

Visitors to the stand can hear from two healthtech innovators Heart2Save and Ainone about their experiences of using Movesense sensor technology to bring new wearable medical solutions to market, and learn how to use the open, programmable Movesense movement and ECG sensor for commercializing their own wearable sensor ideas.

A representative from cardiology start-up Heart2Save, will present its Awario analysis service, a solution that uses the ECG feature of the Movesense sensor with AI based algorithms, allowing users to identify heart arrythmias anytime, anywhere. Awario analyses the ECG to determine whether there is a potentially dangerous atrial fibrillation or harmless extrasystoles. Linked to a smartphone, it generates a normal ECG strip to enable a clinician to analyse the results quickly by selecting only the relevant reports.

Finnish start-up Ainone will talk about how it harnessed tested and certified Movesense technology to launch Ainone Balance, a balance measurement solution for assessing neurological performance. Ainone uses data captured via the Movesense sensor to analyze upper body movement while patients perform different balance tests, such as standing on one foot – eyes open and closed – or on hard or soft ground and compares the results to a unique reference database to monitor changes in human performance. Its applications include elite sports, elderly care, daily balance assessment, and monitoring patient recovery from lower limb injuries and concussions.

Both solutions benefited from Movesense’s open, programmable, off-the-shelf sensor technology to help them overcome the challenges of building and testing hardware and bring healthcare solutions to the market quicker. The Movesense device is a wearable movement and ECG sensor that is classified as a Class IIa medical device accessory under the EU Medical Device Directive. It is small and lightweight (9,4g / 0.33oz with battery),features wireless data transmission with Bluetooth Low Energy, and is available with custom branding and firmware.

More Less

17 Nov 2021

Topic

08:00

Accelerating the development of medical wearables with an open sensor platform

Visitors to the stand can hear from two healthtech innovators Heart2Save and Ainone about their experiences of using Movesense sensor technology to bring new wearable medical solutions to market, and learn how to use the open, programmable Movesense movement and ECG sensor for commercializing their own wearable sensor ideas.

A representative from cardiology start-up Heart2Save, will present its Awario analysis service, a solution that uses the ECG feature of the Movesense sensor with AI based algorithms, allowing users to identify heart arrythmias anytime, anywhere. Awario analyses the ECG to determine whether there is a potentially dangerous atrial fibrillation or harmless extrasystoles. Linked to a smartphone, it generates a normal ECG strip to enable a clinician to analyse the results quickly by selecting only the relevant reports.

Finnish start-up Ainone will talk about how it harnessed tested and certified Movesense technology to launch Ainone Balance, a balance measurement solution for assessing neurological performance. Ainone uses data captured via the Movesense sensor to analyze upper body movement while patients perform different balance tests, such as standing on one foot – eyes open and closed – or on hard or soft ground and compares the results to a unique reference database to monitor changes in human performance. Its applications include elite sports, elderly care, daily balance assessment, and monitoring patient recovery from lower limb injuries and concussions.

Both solutions benefited from Movesense’s open, programmable, off-the-shelf sensor technology to help them overcome the challenges of building and testing hardware and bring healthcare solutions to the market quicker. The Movesense device is a wearable movement and ECG sensor that is classified as a Class IIa medical device accessory under the EU Medical Device Directive. It is small and lightweight (9,4g / 0.33oz with battery),features wireless data transmission with Bluetooth Low Energy, and is available with custom branding and firmware.

More Less

18 Nov 2021

Topic

08:00

Accelerating the development of medical wearables with an open sensor platform

Visitors to the stand can hear from two healthtech innovators Heart2Save and Ainone about their experiences of using Movesense sensor technology to bring new wearable medical solutions to market, and learn how to use the open, programmable Movesense movement and ECG sensor for commercializing their own wearable sensor ideas.

A representative from cardiology start-up Heart2Save, will present its Awario analysis service, a solution that uses the ECG feature of the Movesense sensor with AI based algorithms, allowing users to identify heart arrythmias anytime, anywhere. Awario analyses the ECG to determine whether there is a potentially dangerous atrial fibrillation or harmless extrasystoles. Linked to a smartphone, it generates a normal ECG strip to enable a clinician to analyse the results quickly by selecting only the relevant reports.

Finnish start-up Ainone will talk about how it harnessed tested and certified Movesense technology to launch Ainone Balance, a balance measurement solution for assessing neurological performance. Ainone uses data captured via the Movesense sensor to analyze upper body movement while patients perform different balance tests, such as standing on one foot – eyes open and closed – or on hard or soft ground and compares the results to a unique reference database to monitor changes in human performance. Its applications include elite sports, elderly care, daily balance assessment, and monitoring patient recovery from lower limb injuries and concussions.

Both solutions benefited from Movesense’s open, programmable, off-the-shelf sensor technology to help them overcome the challenges of building and testing hardware and bring healthcare solutions to the market quicker. The Movesense device is a wearable movement and ECG sensor that is classified as a Class IIa medical device accessory under the EU Medical Device Directive. It is small and lightweight (9,4g / 0.33oz with battery),features wireless data transmission with Bluetooth Low Energy, and is available with custom branding and firmware.

More Less

Our range of products

Product categories

  • 06  IT systems and IT solutions
  • 06.03  Wearable technologies, smart textiles

Wearable technologies, smart textiles

Our products

Product category: Wearable technologies, smart textiles

Movesense Medical sensor

Certified for medical use, Movesense Medical is an essential building block to transform your big idea into a new healthcare solution. The programmable, wearable, wireless ECG and movement sensor is used as a measurement device to provide data for medical applications and host devices.  

Main benefits:
  • Programmability – Developers and OEM customers can build custom apps to tailor the functionality of the Movesense Medical sensor for specific use cases. Open API, developer tools, sample code and technical support are available.
  • Time to market – Invest on delivering customer value instead of developing, testing and certifying new hardware. With Movesense Medical as a starting point, you can focus on building and validating your own application.
  • Convenience – The small and lightweight sensor fits for users’ daily life and the flexible supply of sensors with your own branding and your custom firmware smooths your delivery process.
Key features
  • Small and lightweight (9.4g/0.33oz with battery)
  • Wireless data transmission with Bluetooth Low Energy
  • Single channel ECG, heart rate, R-R intervals
  • Movement measurement (9-axis IMU: acceleration, gyro, magnetometer)
  • User replaceable CR 2025 battery
  • Class IIa Medical Device Accessory, EU medical device directive 93/42/EEC
  • Available with custom branding

More Less

About us

Company portrait

Movesense develops and maintains an open development platform for health and sports wearables. The company's mission is to help developers and innovators to turn their wearable sensor ideas into market-ready products quickly and cost-efficiently by reducing the required investment and shortening the time to market for new wearables.

Movesense originated from an internal concept project by the Finnish sports watch manufacturer Suunto. It proved to be so versatile that the company offered it to third parties for the implementation of new product concepts.

Movesense development started in 2015 and the platform was published in the end of 2016. Developers received the first beta versions of the sensor in the spring of 2017 and the 1.0 firmware for the sensor was published in 2017.

Movesense is now used by healthcare and sports technology innovators across the globe in applications ranging from cardiology to orthopaedics and various sports monitoring solutions for all performance levels.

On October 1st 2021, Movesense became an independent company and continues to build the development platform for both medical and sports use in close collaboration with Suunto.

Company data

Foundation 2021
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Physiotherapy / orthopaedic technology
  • IT systems and IT solutions